Functional Genomic Profiling of Schizophrenia-Associated Genes Reveals Key Microglial Regulators

Joy E Horng1,2, Liam T McCrea1, Rebecca E Batorsky3

  • 1Center for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.

Insights

This study used CRISPR screening to investigate schizophrenia-associated genes in microglia, revealing key genes that impact microglial function and identify potential therapeutic targets for schizophrenia.

Area of Science:

  • Neuroscience
  • Genetics
  • Immunology

Background:

  • Microglia regulate neural development and are implicated in schizophrenia (SCZ).
  • The functional roles of SCZ-associated genes within microglia are largely unknown.
  • Understanding microglial gene function is crucial for SCZ pathophysiology.

Purpose of the Study:

  • To functionally characterize SCZ-associated genes in human microglia-like cells.
  • To identify specific genes impacting microglial phagocytosis and activation.
  • To explore the transcriptional consequences of targeting SCZ-associated genes.

Main Methods:

  • Arrayed CRISPR screening of 30 SCZ-associated genes in human microglia-like cells.
  • High-content confocal imaging to quantify phagocytic activity and cell morphology.
  • Multiplexed RNA sequencing to analyze transcriptional changes post-gene targeting.

Main Results:

  • CRISPR screening identified key genes (e.g., CYFIP1, MSR1, TREM2, SYK, ITGB2, ITGAM, IRF8) modulating microglial phagocytosis and morphology.
  • Targeted genes induced morphological changes indicative of microglial activation states.
  • RNA sequencing revealed gene-specific transcriptional signatures linked to phagocytic, activation, cytoskeletal, and lysosomal pathways.

Conclusions:

  • CRISPR-based functional genomics is effective for characterizing microglial function.
  • Identified SCZ-associated genes have direct functional impacts on microglia.
  • These findings highlight novel genes and mechanisms relevant to schizophrenia pathophysiology.